No Detail Found!

Prognostic evaluation of guillain - barre' syndrome

Author(s)
Fareed Ullah Shah Department of Neurology, Pakistan Institute of Medical Sciences, Islamabad.Pakistan
Muhammad Azhar Saeed Department of Neurology, Pakistan Institute of Medical Sciences, Islamabad.Pakistan
Mazhar Badsha Department of Neurology, Pakistan Institute of Medical Sciences, Islamabad, Pakistan
Muhammad Tariq Department of Neurology, Pakistan Institute of Medical Sciences, Islamabad.Pakistan
Abstract
To study the mortality, morbidity and the role of specific therapy in Guillain-Barre’ syndrome (GBS). Design: This was a prospective study. Place and Duration of Study: This study was conducted in the Department of Neurology, RIMS, Islamabad from January, 1999 to September, 2000. A Subjects and Methods: Forty-eight patients with acute symmetrical flaccid motor weakness, which developed within a period of four weeks, were included. These patients were assessed at admission, discharge and after 2 and 6 months according to the modified Rankin Scale Score. Patients with sensory level and those having marked and persistent asymmetry of neurological signs were excluded from the study. Results: The modified disability score (DS) in the patients at admission was 2-5 in 2, 11, 19 and 16 patients, respectively. Respiratory failure was present in 16 patients. Six patients expired. After 2 months, 19 recovered^ 10 were lost and disability was present in 13 patients. After 6 months, 20 recovered and 5 were disabled^ Specific treatment was given to 23 patients, plasmapheresis was done in 10 patients, gammaglobulin given to 4 patients and both in 9 patients. In plasmapheresis group at admission DS was 4, 5 and 7 in 3 patients respectively. Three patients expired. At 2 months, 2 recovered, 3 disabled while 2 patients were lost. At 6 months, 2 recovered 1 disabled while 4 were lost. Similarly, in gammaglobulin group DS was 4 and 5 in 3 and 1 patient at admission. At 2 months, 3 recovered and 1 was disabled. In the combined group, admission DS was 4 in 1 and 5 in 8 patients. At 2 months, 3 recovered, 5 disabled and 1 patient was lost. At 6 months, 3 recovered and 2 patients were disabled. In the non- specific treatment group, DS was 2 and 3 in 2 and 11 patients at admission. At 2 months, 9 recovered and 3 were disabled while 1 was lost. At 6 months, 11 patients recovered and 2 were disabled. In the control group, at admission, DS was 4 in 8 and 5 in 4 patients. DS at discharge was 2 in 2 and 4 in 7 patients, while 3 patients expired. At 2-month, 2 recovered, DS was 4 in 1 patient while 6 were lost in the follow-up. Conclusion: Gammaglobulin was better than plasmapheresis as far as morbidity and mortality is concerned. Patients with DS 3 or less may be managed without specific treatment. In patients with DS 4 or more, treatment should be started as early as possible for better outcome.
Publication Details
Page(s) 437-442
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 11, Issue: 7, Year: 2001

Request the full text from PASTIC

Keywords
Polyradiculoneuritis. Guillain -Barre’ syndrome. Disability evaluation.
References
Khalili-ShiraazAi ,Gay I,Rees J,Hughes R. Antigangliosideantibodiesin J .1999 .GuillainBarr'esyndromeaftera recenctytomegaloviruinsfection. JNeuro!NeurosurgPsychiat, 66 : 376-9.
McKhannGM CornblatDhR,Ho T,Li CY,Bai AY,Wu HS,Odaka M,Yuki N .1999 .Bilaterabalilismin a patient paralytidciseaseof childrenand young adultsin with overlapping Fishe r's and Guillain-Bar' re northerCnhina. JNeuro!NeurosurgPsychiat, 67 : 206-8.
Van DerMeche FGA,Van DoornPA,Van DerMeche FGA,DutchGuillain-Bar're J .1992 .rseyndrome studygroupA. randomizedtriaclomparingintravenous withoutsensoryloss (acutemotorneuropathy).A immune globulinand plasmaexchangein Guillainsubgroupwith specificclinicale,lectrodiagnosatincd Barr'esyndrome. NEng!JMed, 118 : 841-7.
Logina I .1999 .clinicalstudy and comparisonwith Guillain-Bar' re syndrome. JNeuro!NeurosurgPsychiat, 67 : 433-8.
0

Citations

0

Downloads

44

Views